Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $27.0000 (4.19%) ($27.0000 - $27.0200) on Fri. Jun. 25, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.47% (three month average) | RSI | 90 | Latest Price | $27.0000(4.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 2% a day on average for past five trading days. | Weekly Trend | IOVA advances 7.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(45%) XBI(42%) IWO(41%) ARKG(40%) IWC(39%) | Factors Impacting IOVA price | IOVA will decline at least -3.235% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-11%) TBT(-5%) UNG(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.235% (StdDev 6.47%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $25.3(6.72%) | 10 Day Moving Average | $24.78(8.96%) | 20 Day Moving Average | $22.47(20.16%) | To recent high | -18.2% | To recent low | 67.1% | Market Cap | $3.954b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |